-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Propanc Biopharma, Inc. quarterly Share-based Payment Arrangement, Expense history and growth rate from Q3 2021 to Q3 2022.
- Propanc Biopharma, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2022 was $0.000, a 100% decline year-over-year.
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)